Trastuzumab emtansine in locally advanced or metastatic HER2 positive breast cancer; GENESIS-SEFH drug evaluation report

Trastuzumab emtansina (T-DM1) is an antibody-drug conjugate directed against the HER2 for the treatment of HER2+ mestastatic breast cancer (MBC), who has previously received trastuzumab plus a taxane. According to the results of the EMILIA trial versus lapatinib plus capecitabine T-DM1 shows a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Patricia Miranda Romero, Roberto Marín Gil
Formato: Artigo
Idioma:Inglês
Publicado em: Grupo Aula Médica 2015-02-01
Colecção:Farmacia Hospitalaria
Assuntos:
Breast Cancer
Trastuzumab emtansine
; Cost-effectiveness
; Lapatinib
Acesso em linha:http://www.aulamedica.es/fh/pdf/8912.pdf
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados